Furthermore, Clay and colleagues demonstrated that ALDH+ cancer cells isolated from a primary OSCC tumor were ten times more tumorigenic than CD44+-only cells, strongly supporting the use of ALDH as a more discriminatory marker for CSCs in HN-/OSCC [47]. This evidence concerns the gene CD44 and cancer.